Bukwang Pharmaceutical Co., Ltd.
Research Bukwang Pharmaceutical Co., Ltd. (003000.KS) on Bullrun: market cap KRW 384.79B, dividend yield 1.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker003000.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 384.79B
- Dividend yield1.8%
- Financial periodQ2 2026
- RevenueKRW 56.99B
- Net incomeKRW 1.40B
- Free cash flow-KRW 18.95M
- Gross margin42.8%
Valuation Snapshot
latest market cap is KRW 384.79B; dividend yield is 1.8%.
Peer valuation comparison
Latest dividend yield is 1.84% versus a Healthcare sector median of 2.4% (23.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 384.79B | n/a | 3.2% | 125 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 125 KRW, yield 1.8%.
About Bukwang Pharmaceutical Co., Ltd.
Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia;
ETFs that hold Bukwang Pharmaceutical Co., Ltd.
US-listed ETFs
Bukwang Pharmaceutical Co., Ltd. is held by 15 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) | <0.01% | 0.03% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| State Street SPDR Portfolio Developed World ex-US ETF (SPDW) | <0.01% | 0.03% |
| Vanguard FTSE Pacific Index Fund ETF Shares (VPL) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | <0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bukwang Pharmaceutical Co., Ltd.'s market cap?
Bukwang Pharmaceutical Co., Ltd.'s market capitalization is KRW 384.79B.
Does Bukwang Pharmaceutical Co., Ltd. pay a dividend?
Bukwang Pharmaceutical Co., Ltd. has a dividend yield of 1.8%.
What does Bukwang Pharmaceutical Co., Ltd. do?
Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments.